The eventual FDA approval of the bupropion-naltrexone combination (Contrave) provided one of the first clinical demonstrations that anti-addiction medications acting on reward pathways could also reduce overeating
The most commonly reported side effects are gastrointestinal and may include nausea, diarrhea, vomiting, constipation, stomach discomfort, bloating, and indigestion, particularly when first starting treatment or increasing dose
Nuklearmedizin 53(06):227337 Oeltzschner G, Zllner HJ, Hui SCN, Mikkelsen M, Saleh MG, Tapper S et al (2020) Osprey: open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data
No clinical evidence supports their effectiveness for weight loss
L-Carnitine enhances exercise endurance capacity by promoting muscle oxidative metabolism in mice